AstraZeneca (AZN LN)

203

Analysis

Health Care • United Kingdom

AstraZeneca is a Swedish-British multinational pharmaceutical and biotechnology company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was formed in 1999 through the merger of Astra AB and Zeneca Group PLC and is headquartered in Cambridge, UK.

Refresh

Exchange Announcement • 05 Oct 2026 18:00

AstraZeneca completes equity investment in Summit

Exchange Announcement • 02 Oct 2026 13:30

AZ & DS collaboration with Summit for Datroway

Exchange Announcement • 01 Oct 2026 21:05

Admission of Further Securities to Trading

Exchange Announcement • 01 Oct 2026 21:00

Total Voting Rights

Exchange Announcement • 29 Sep 2026 13:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AstraZeneca completes equity investment in Summit

AZ & DS collaboration with Summit for Datroway

Admission of Further Securities to Trading

Total Voting Rights

AstraZeneca announces equity investment in Summit